Introduction
Determination of oestrone sulphate concentrations in plasma and urine have been used to diag¬ nose pregnancy after Day 40 of pregnancy in the mare and to monitor the viability of the horse fetus (Terqui & Palmer, 1979; Kindahl et ai, 1982; Evans et ai, 1984; Hyland et ai, 1984; Darenius et ai, 1988; Kasman et ai, 1988; Varner et ai, 1988) . While oestrogen concentrations during the first 30 days of pregnancy are not different from the non-pregnant mare, plasma con¬ centrations of oestrogen conjugates increase 2-3-fold between Days 35 and 40 of gestation. After this increase, oestrogen concentrations tend to plateau until Day 70-80 when they increase again with values remaining significantly higher for the rest of pregnancy (Nett et ai, 1975; Stewart et ai, 1982) .
The horse embryo is able to synthesize oestrogens as early as Day 7 after conception (Flood et ai, 1979; Heap et ai, 1982; Zavy et ai, 1984) . The close temporal relationship between the increase in oestrogen secretion at Day 40 and the onset of horse chorionic gonadotrophin (CG) secretion by the endometrial cups has led to the hypothesis that fetal oestrogen secretion may be stimulated by horse CG (Ginther, 1979) . Surgical removal of the fetus and prostaglandin-induced abortion, between Days 44 and 89 of pregnancy, have been shown to result in a significant reduction in urinary oestrone sulphate concentrations, suggesting a correlation between oestrogen production and viability of the fetus (Kasman et ai, 1988) . A similar decrease in oestrogen secretion was seen following induction of fetal death at Day 45 by means of injection of hypertonic saline into the fetal sac (Jeffcott et ai, 1987 (Varner et ai, 1988) . All these observations suggest that the horse fetus is an important source of oestrogens and that changes in oestrogen secretion are a direct reflection of fetal viability.
On the other hand, Terqui & Palmer (1979) (Terqui & Palmer, 1979; Kasman et ai, 1988) 17a-allyl-17ß-hydroxyoestra-4,9,ll-trien-3-one) was used as a progesterone replacement treatment (Shideler et ai, 1982 Oestrogen conjugate concentrations in urine were determined with a direct radioimmunoassay (RIA). The antibody (R-583) was produced in rabbits and was directed against oestrone-3-glucuronide which had been conjugated to bovine serum albumin. The antiserum was used at a dilution of 1:8000 in Tris buffer (01 M-Tris pH 8-4, 0 1% gelatin, 0-9% NaCl, 0-1% sodium azide). When using oestrone-3-sulphate as the standard (100%), the antibody cross-reacted with oestrone (200%), oestradiol-17ß (100%), equilin (50%), oestrone-3-glucuronide (38%), oestradiol-3-sulphate(21%), and oestradiol-3-glucuronide (6-8%); the cross-reaction was less than 0-5% with all non-oestrogenic steroids tested. For the assay, urine samples were diluted 1:100 in distilled water and 005 ml was assayed. Serially diluted urine samples produced displacement curves parallel to the oestrone sulphate standards. The limit of the sensitivity was 0-018 ng/tube or 0-36 ng/ml plasma or 36 ng/ml urine. The inter-assay coefficients of variation were 13% (« = 10) to 21% (« = 15) at 20-30% binding and 10% (n = 15) to 12% (n = 9) at 50-60% binding on the standard curve; the intra-assay coefficient of variation was 6-9%. The details of the assay, with the exception of the antiserum used, have been described previously (Shideler el ai, 1983a, b) .
Plasma progesterone concentrations were determined in plasma using an enzyme immunoassay (Munro & Stabenfeldt, 1984) . The antibody cross-reacts with 1 la-hydroxyprogesterone (21-4%), 5a-pregnane-3,20-dione (29-5%), and 20ß-dihydroprogesterone (2-4%) while the cross-reaction is <0-5% for 17ct-hydroxyprogesterone, oestradiol-17ß, Cortisol, A4-androstenedione and testosterone. The limit of sensitivity of the assay was 2-5 pg/ml. The inter-assay coefficient of variation ranged from I -2 to 4-3% at different concentrations of hormone and the intra-assay coefficient of variation ranged from 2-7 to 8-4%.
Horse CG concentrations were determined by radioimmunoassay (Roser & Lofstedt, 1989) .
Creatinine concentrations were used to index the urinary oestrogen conjugate concentrations to compensate for variations in the specific gravity of urine. Urinary creatinine concentrations were determined by modification of a colorimetrie method (Taussky, 1954 (1974) reported that follicular dynamics in hysterectomized pony mares between Days 10 and 68 after ovulation paralleled the changes occurring in pregnant mares over the same time span, thus indicating that pregnancy per se had no effect on follicular status.
Lowered oestrogen excretion in mares treated with altrenogest (Groups I and III) may indicate a direct effect of the synthetic steroid on oestrogen synthesis. Since altrenogest is structurally differ¬ ent from progesterone, with 2 extra double bounds and an allyl-group in the 17 position, it may interfere with some progesterone-dependent events. Marsan et al. (1987) have suggested a two-cell system for oestradiol synthesis in the horse embryo. Progesterone produced by one cell is trans¬ ported to another cell for conversion to oestradiol, as is believed to occur in ovarian follicles. It is possible that altrenogest blocks those enzymes, aromatase and desmolase, necessary for oestradiol production. Although this possibility needs to be investigated, comparison with previous results indicates that the effect of altrenogest on oestradiol synthesis is negligible (Terqui & Palmer, 1979; Kasman et ai, 1988 ).
In the non-pregnant mare, the maturation of Graafian follicles is characterized by an increase in both oestradiol-17ß and oestrogen conjugate whereas there is no increase in oestradiol-17ß associ¬ ated with the increase in oestrogen conjugates concentrations before Day 70 of gestation, suggest¬ ing that the oestrogens secreted in early pregnancy may be from a source other than antral follicles (Nett et ai, 1975) . Our preliminary work has shown that the oestrogen peak on Day 39 is absent in pregnant mares in which the primary corpus luteum was eliminated by administration of prosta¬ glandin F-2a and pregnancy was maintained by daily altrenogest administration. It is postulated that horse CG stimulates oestrogen secretion by the primary corpus luteum. The effect of horse CG in the mare appears to be similar to the effect of hCG in pregnant women, in which the secretion of hCG is associated with an increased oestrogen secretion (Lasley et ai, 1985) . The concept that the corpus luteum is a source of oestrogen after Day 35 of pregnancy is not necessarily in disagreement with the decrease in oestrogen secretion observed after termination of pregnancy in the first third of pregnancy in that the methods used to terminate pregnancy (PGF-2a administration, surgical removal of the fetus or injection of hypertonic solution into the allantóte sac) may have caused regression of the primary corpus luteum (Jeffcott et ai, 1987; Kasman et ai, 1988 (Nett et ai, 1975; Stewart et ai, 1982) and both maternal and fetal gonadectomy have identified the fetal gonads and placenta as the source of oestrogens and progestagens in mid-gestation (Raeside et ai, 1973; Pashen & Allen, 1979a, b; Stewart et ai, 1982) .
From our data during the first 70 days of pregnancy it appears that the ovary is a major source of oestrogen. The first significant increase in oestrogen concentrations which begins at about Day 35 is an ovarian response (probably luteal) to the secretion of horse CG and thus reflects the formation of endometrial cups rather than an increase in oestrogen secretion by the feto-placental unit. After Day 80, the feto-placental unit becomes the dominant oestrogen source and changes in circulating oestrogen concentrations are a reflection of fetal secretion.
